AFAlexey Fomenko

Alexey Fomenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexey Fomenko has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of Different Methods for the Meta‐Analysis of Diagnostic Test Accuracy Studies—A Simulation Study

    by Ferdinand V. Stoye, Olaf Raths, Alexander Hapfelmeier, Alexey Fomenko, Oliver Kuss, Annika Hoyer

    Meta‐analysis of diagnostic test accuracy studies aggregates information from multiple studies on sensitivity and specificity. Classical approaches select a single pair of sensitivity and specificity per study (single threshold methods, STM), ignoring additional information if studies report results on multiple diagnostic thresholds. Recently, models have been proposed that consider all available information and enable inference on all diagnostic thresholds (multiple threshold methods, MTM). We compare five STM and six MTM to each other in a simulation study, evaluating their performance in various situations. Covering a broad range of real‐life settings, we vary eight parameter dimensions in the data‐generation mechanisms, including continuous or ordinal outcome type of an index test, and different numbers of diagnostic thresholds available per study. While model performances are comparable regarding bias, empirical coverage, and convergence, we observe a logit GLMM of the MTM type to perform best in many situations. Model performances depend strongest on the outcome type, while the number of thresholds only has a minor impact. We thus find the main advantage of using MTM by getting threshold‐dependent estimates of sensitivity and specificity. Additionally, we illustrate differences between model estimates in two real‐data examples on diagnosing type 2 diabetes using the continuous biomarker HbA1c and screening for any anxiety disorder using the ordinal questionnaire HADS‐A. The applications reveal variations in model estimates within and between STM and MTM, which can be reduced by adjusting for the bias in the simulation settings resembling the real‐data situation most closely.


  • Comparative test accuracy of eight self-rating scales for screening for anxiety disorders among adults: protocol for a network meta-analysis

    by Klaus Linde, Enzo Cerullo, Alexey Fomenko, Zekeriya Aktürk, Stefanie Eck, Daniel Dümmler, Hayley E Jones, Efthymia Derezea, Alexander Hapfelmeier, Alex J Sutton, et al.

    INPLASY202570014 Comparative test accuracy of eight self-rating scales for screening for anxiety disorders among adults: protocol for a network meta-analysis Keywords: Diagnostic test accuracy, scr…


  • Open Access

    Test accuracy of rapid diagnostic tests and reverse‐transcription polymerase chain reaction against virus isolation in cell culture for assessing SARS‐CoV‐2 infectivity: Systematic review and meta‐analysis

    by Alexey Fomenko, Theo Dähne, Stephanie Weibel, Marcus Panning, Kathrin Grummich, Sabrina Schlesinger, Gerta Rücker, Hartmut Hengel

    We aimed to assess the performance of Ag‐RDT and RT‐qPCR with regard to detecting infectious SARS‐CoV‐2 in cell cultures, as their diagnostic test accuracy (DTA) compared to virus isolation remains largely unknown. We searched three databases up to 15 December 2021 for DTA studies. The bivariate model was used to synthesise the estimates. Risk of bias was assessed using QUADAS‐2/C. Twenty studies (2605 respiratory samples) using cell culture and at least one molecular test were identified. All studies were at high or unclear risk of bias in at least one domain. Three comparative DTA studies reported results on Ag‐RDT and RT‐qPCR against cell culture. Two studies evaluated RT‐qPCR against cell culture only. Fifteen studies evaluated Ag‐RDT against cell culture as reference standard in RT‐qPCR‐positive samples. For Ag‐RDT, summary sensitivity was 93% (95% CI 78; 98%) and specificity 87% (95% CI 70; 95%). For RT‐qPCR, summary sensitivity (continuity‐corrected) was 98% (95% CI 95; 99%) and specificity 45% (95% CI 28; 63%). In studies relying on RT‐qPCR‐positive subsamples (n = 15), the summary sensitivity of Ag‐RDT was 93% (95% CI 92; 93%) and specificity 63% (95% CI 63; 63%). Ag‐RDT show moderately high sensitivity, detecting most but not all samples demonstrated to be infectious based on virus isolation. Although RT‐qPCR exhibits high sensitivity across studies, its low specificity to indicate infectivity raises the question of its general superiority in all clinical settings. Study findings should be interpreted with caution due to the risk of bias, heterogeneity and the imperfect reference standard for infectivity.


  • Open Access

    Hemoglobin Rothschild – Unimpaired physical performance and oxygen uptake – A case report with literature review

    by Alexey Fomenko, Thomas Kolokowski, Detlev Heyse, Polina Petkova, Malak Hassan, Kaweh Rezazadegan, Niklas Walther, Dominic Dellweg


  • Open Access

    Acute Viral Gastrointestinal (GI) Infections in the Tropics—A Role for Cartridge-Based Multiplex PCR Panels?

    by Stefanie Kramme, Theo Dähne, Alexey Fomenko, Marcus Panning

    Acute gastroenteritis (AGE) contributes to increased morbidity and mortality worldwide. In particular, children in resource-poor settings suffer from frequent episodes of diarrhea. A variety of pathogens, including bacteria, viruses, fungi, and protozoa, can cause AGE. Common viruses associated with AGE are norovirus, rotavirus, astrovirus, adenovirus, and sapovirus. Due to their similar clinical presentation, AGE pathogens cannot be distinguished on clinical grounds rendering the etiological diagnosis challenging. However, reliable diagnosis is essential for individual and public health reasons, e.g., to limit transmission, for appropriate antibiotic use, prognostic appreciation, and vaccination programs. Therefore, high-quality data derived by accurate diagnostics are important to improve global health. In Western industrialized countries, diagnosis relies on microbiological testing, including culture methods, microscopy, immunochromatography, and single-target molecular methods. Recently, multiplex PCR or syndromic panels have been introduced, which simultaneously analyze for multiple pathogens in a very short time. A further technological advancement is cartridge-based syndromic panels, which allow for near patient/point-of-care testing independently from a laboratory. In resource-poor tropical regions, however, laboratory diagnosis is rarely established, and there are little routine laboratory data on the epidemiology of viral AGE pathogens. Limiting factors for the implementation of syndromic panels are high costs, sophisticated equipment, and the need for trained personnel. In addition, pilot studies have shown a large number of viral (co-)detections among healthy controls, thus further challenging their clinical utilization. Hence, there are little evidence-based data on the impact of multiplex syndromic panels from resource-limited regions. Here, we aim to provide a brief overview of what is known about the use of syndromic panels for virus-associated AGE in tropical regions and to address future challenges.


  • Open Access

    Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse‐transcription polymerase chain reaction: A systematic review and meta‐analysis

    by Alexey Fomenko, Stephanie Weibel, Helia Moezi, Kristina Menger, Christine Schmucker, Maria‐Inti Metzendorf, Edith Motschall, Valeria Falcone, Daniela Huzly, Marcus Panning, et al.

    The cornerstone of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) detection is reverse‐transcription polymerase chain reaction (RT‐PCR) of viral RNA. As a surrogate assay SARS‐CoV‐2 RNA detection does not necessarily imply infectivity. Only virus isolation in permissive cell culture systems can indicate infectivity. Here, we review the evidence on RT‐PCR performance in detecting infectious SARS‐CoV‐2. We searched for any studies that used RT‐PCR and cell culture to determine infectious SARS‐CoV‐2 in respiratory samples. We assessed (i) diagnostic accuracy of RT‐PCR compared to cell culture as reference test, (ii) performed meta‐analysis of positive predictive values (PPV) and (iii) determined the virus isolation probabilities depending on cycle threshold (Ct) or log10 genome copies/ml using logistic regression. We included 55 studies. There is substantial statistical and clinical heterogeneity. Seven studies were included for diagnostic accuracy. Sensitivity ranged from 90% to 99% and specificity from 29% to 92%. In meta‐analysis, the PPVs varied across subgroups with different sampling times after symptom onset, with 1% (95% confidence interval [CI], 0%–7%) in sampling beyond 10 days and 27% (CI, 19%–36%) to 46% (CI, 33%–60%) in subgroups that also included earlier samples. Estimates of virus isolation probability varied between 6% (CI, 0%–100%) and 50% (CI, 0%–100%) at a Ct value of 30 and between 0% (CI, 0%–22%) and 63% (CI, 0%–100%) at 5 log10 genome copies/ml. Evidence on RT‐PCR performance in detecting infectious SARS‐CoV‐2 in respiratory samples was limited. Major limitations were heterogeneity and poor reporting. RT‐PCR and cell culture protocols need further standardisation.


  • Open Access

    Dynamic Regulation of GH–IGF1 Signaling in Injury and Recovery in Hyperoxia-Induced Neonatal Lung Injury

    by Christina Vohlen, Jasmine Mohr, Alexey Fomenko, Celien Kuiper-Makris, Tiffany Grzembke, Rabia Aydogmus, Rebecca Wilke, Dharmesh Hirani, Jörg Dötsch, Miguel A. Alejandre Alcazar

    Prematurely born infants often require supplemental oxygen that impairs lung growth and results in arrest of alveolarization and bronchopulmonary dysplasia (BPD). The growth hormone (GH)- and insulin-like growth factor (IGF)1 systems regulate cell homeostasis and organ development. Since IGF1 is decreased in preterm infants, we investigated the GH- and IGF1 signaling (1) in newborn mice with acute and prolonged exposure to hyperoxia as well as after recovery in room air; and (2) in cultured murine lung epithelial cells (MLE-12) and primary neonatal lung fibroblasts (pLFs) after treatment with GH, IGF1, and IGF1-receptor (IGF1-R) inhibitor or silencing of GH-receptor (Ghr) and Igf1r using the siRNA technique. We found that (1) early postnatal hyperoxia caused an arrest of alveolarization that persisted until adulthood. Both short-term and prolonged hyperoxia reduced GH-receptor expression and STAT5 signaling, whereas Igf1 mRNA and pAKT signaling were increased. These findings were related to a loss of epithelial cell markers (SFTPC, AQP5) and proliferation of myofibroblasts (αSMA+ cells). After recovery, GH-R-expression and STAT5 signaling were activated, Igf1r mRNA reduced, and SFTPC protein significantly increased. Cell culture studies showed that IGF1 induced expression of mesenchymal (e.g., Col1a1, Col4a4) and alveolar epithelial cell type I (Hopx, Igfbp2) markers, whereas inhibition of IGF1 increased SFTPC and reduced AQP5 in MLE-12. GH increased Il6 mRNA and reduced proliferation of pLFs, whereas IGF1 exhibited the opposite effect. In summary, our data demonstrate an opposite regulation of GH- and IGF1- signaling during short-term/prolonged hyperoxia-induced lung injury and recovery, affecting alveolar epithelial cell differentiation, inflammatory activation of fibroblasts, and a possible uncoupling of the GH-IGF1 axis in lungs after hyperoxia.